Login / Signup

ATP-degrading ENPP1 is required for survival (or persistence) of long-lived plasma cells.

Hongsheng WangInes Gonzalez-GarciaJavier TrabaShweta JainSolomon ContehDong-Mi ShinChenfeng QiYuanyuan GaoJiafang SunSungyun KangSadia AbbasiZohreh NaghashfarJeongheon YoonWendy DuBoisAlexander L KovalchukMichael N SackPatrick Emmet DuffyHerbert C Morse
Published in: Scientific reports (2017)
Survival of antibody-secreting plasma cells (PCs) is vital for sustained antibody production. However, it remains poorly understood how long-lived PCs (LLPCs) are generated and maintained. Here we report that ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) is preferentially upregulated in bone marrow LLPCs compared with their splenic short-lived counterparts (SLPCs). We studied ENPP1-deficient mice (Enpp1 -/- ) to determine how the enzyme affects PC biology. Although Enpp1 -/- mice generated normal levels of germinal center B cells and plasmablasts in periphery, they produced significantly reduced numbers of LLPCs following immunization with T-dependent antigens or infection with plasmodium C. chabaudi. Bone marrow chimeric mice showed B cell intrinsic effect of ENPP1 selectively on generation of bone marrow as well as splenic LLPCs. Moreover, Enpp1 -/- PCs took up less glucose and had lower levels of glycolysis than those of wild-type controls. Thus, ENPP1 deficiency confers an energetic disadvantage to PCs for long-term survival and antibody production.
Keyphrases
  • bone marrow
  • wild type
  • induced apoptosis
  • mesenchymal stem cells
  • cell cycle arrest
  • type diabetes
  • metabolic syndrome
  • cell therapy
  • stem cells
  • cell death
  • dendritic cells
  • blood glucose
  • free survival
  • replacement therapy